1. Home
  2. TISI vs RANI Comparison

TISI vs RANI Comparison

Compare TISI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

N/A

Current Price

$26.96

Market Cap

101.4M

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

N/A

Current Price

$0.82

Market Cap

106.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TISI
RANI
Founded
1973
2012
Country
United States
United States
Employees
6800
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.4M
106.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TISI
RANI
Price
$26.96
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
28.7K
623.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
$896,483,000.00
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
5.19
58.85
52 Week Low
$12.34
$0.45
52 Week High
$28.05
$3.87

Technical Indicators

Market Signals
Indicator
TISI
RANI
Relative Strength Index (RSI) 68.14 47.00
Support Level $15.93 $0.76
Resistance Level $28.05 $0.83
Average True Range (ATR) 1.32 0.04
MACD -0.08 -0.01
Stochastic Oscillator 79.01 25.62

Price Performance

Historical Comparison
TISI
RANI

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: